Table 2.
LDL cholesterol (LDL-C) analysis of male patients treated with and without Finasteride: NHANES 2009–2016a
| LDL cholesterol levels in subjects taking finasteride: NHANES 2009-2016 | ||||||
|---|---|---|---|---|---|---|
| Interaction variable | No finasteride |
Finasteride |
p | Test for interaction |
||
| Mean ± SE | Mean ± SE | F | p | |||
| Diagnosed high blood cholesterol (Diagnosed) and/or taking medications for blood cholesterol (Meds) | Diagnosed + Meds | 103 ± 6 | 83 ± 9 | 0.018 | 2.3 | 0.086 |
| Diagnosed + No meds | 129 ± 8 | 102 ± 10 | 0.017 | |||
| Not diagnosed + Meds | 90 ± 7 | 61 ± 11 | 0.017 | |||
| Not diagnosed + No meds | 102 ± 5 | 91 ± 7 | 0.074 | |||
| Taking drugs that affect glucose metabolism | Yes | 102 ± 5 | 87 ± 5 | 0.008 | 3.58 | 0.063 |
| No | 111 ± 6 | 81 ± 8 | 0.0002 | |||
a
Statistical differences were considered significant when P < 0.05 and P < 0.15 for differences in means between No finasteride and Finasteride groups and the Test for interaction, respectively. LDL-C units: mg/dl.